Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of telmisartan in hypertensive hemodialysis patients with chronic renal insufficiency
2007-004403-34Phase 4Active
- Sponsor
- Fundació Puigvert
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of telmisartan in hypertension (HTN), chronic kidney disease (CKD) and end-stage kidney disease (ESKD), sponsored by Fundació Puigvert. Primary endpoint: Change in systolic and diastolic blood pressure by ABPM at 16 weeks. Started Dec 2007; status: active.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2007-004403-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004403-34.